XML 55 R44.htm IDEA: XBRL DOCUMENT
v3.20.2

SEGMENT INFORMATION (Tables) | 9 Months Ended
--- | ---
Jul. 31, 2020
Segment Reporting [Abstract] |
Segment Profitability and Segment Assets | The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.
| July 31, 2020 |  | October 31, 2019
| (in millions)
Segment Assets: |  |  |
Life Sciences and Applied Markets | $ | 3,121 |  |  | $ | 3,202 |
Diagnostics and Genomics | 2,518 |  |  | 2,620 |
Agilent CrossLab | 1,361 |  |  | 1,331 |
Total segment assets | $ | 7,000 |  |  | $ | 7,153 |
The profitability of each of the segments is measured after excluding transformational initiatives, acquisition and integration costs, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization, impairment of acquisition-related intangibles and other items as noted in the reconciliations below:
| Three Months Ended |  | Nine Months Ended
| July 31, |  | July 31,
| 2020 |  | 2019 |  | 2020 |  | 2019
| (in millions)
Net Revenue: |  |  |  |  |  |  |
Life Sciences and Applied Markets | $ | 557 |  |  | $ | 544 |  |  | $ | 1,721 |  |  | $ | 1,680 |
Diagnostics and Genomics | 241 |  |  | 263 |  |  | 753 |  |  | 752 |
Agilent CrossLab | 463 |  |  | 467 |  |  | 1,382 |  |  | 1,364 |
Total net revenue | $ | 1,261 |  |  | $ | 1,274 |  |  | $ | 3,856 |  |  | $ | 3,796 |
Segment Income From Operations: |  |  |  |  |  |  |  |  |
Life Sciences and Applied Markets | $ | 126 |  |  | $ | 118 |  |  | $ | 382 |  |  | $ | 384 |
Diagnostics and Genomics | 41 |  |  | 50 |  |  | 132 |  |  | 132 |
Agilent CrossLab | 132 |  |  | 122 |  |  | 373 |  |  | 342 |
Total segment income from operations | $ | 299 |  |  | $ | 290 |  |  | $ | 887 |  |  | $ | 858 |
Reconciliation of segment results to total enterprise results | The following table reconciles segment income from operations to Agilent’s total enterprise income before taxes:
| Three Months Ended |  | Nine Months Ended
| July 31, |  | July 31,
| 2020 |  | 2019 |  | 2020 |  | 2019
| (in millions)
Total segment income from operations | $ | 299 |  |  | $ | 290 |  |  | $ | 887 |  |  | $ | 858 |
Transformational initiatives | (13 | ) |  | (11 | ) |  | (41 | ) |  | (25 | )
Amortization of intangible assets related to business combinations | (45 | ) |  | (25 | ) |  | (139 | ) |  | (79 | )
Acquisition and integration costs | (9 | ) |  | (12 | ) |  | (33 | ) |  | (32 | )
Asset impairment | — |  |  | — |  |  | (99 | ) |  | — |
Acceleration of share-based compensation expense | (1 | ) |  | — |  |  | (1 | ) |  | — |
NASD site costs | — |  |  | (6 | ) |  | — |  |  | (12 | )
Special compliance costs | — |  |  | (1 | ) |  | — |  |  | (2 | )
Other(1) | (1 | ) |  | (10 | ) |  | (27 | ) |  | (17 | )
Interest income | 1 |  |  | 10 |  |  | 7 |  |  | 30 |
Interest expense | (19 | ) |  | (18 | ) |  | (59 | ) |  | (53 | )
Other income (expense), net (2) | 7 |  |  | 5 |  |  | 64 |  |  | 20 |
Income before taxes, as reported | $ | 219 |  |  | $ | 222 |  |  | $ | 559 |  |  | $ | 688 |
(1) The other category primarily includes the legal costs related to a claim we pursued against Twist Bioscience Corporation in addition to other miscellaneous adjustments. (2) Other income (expense), net for the nine months ended July 31, 2020 includes the settlement of the legal claim against Twist Bioscience Corporation.

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration